L
Lluis Colomo
Researcher at University of Barcelona
Publications - 52
Citations - 2892
Lluis Colomo is an academic researcher from University of Barcelona. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 18, co-authored 46 publications receiving 2621 citations. Previous affiliations of Lluis Colomo include John Radcliffe Hospital & Pompeu Fabra University.
Papers
More filters
Journal ArticleDOI
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.
Joaquim Carreras,Armando López-Guillermo,Armando López-Guillermo,Bridget C. Fox,Bridget C. Fox,Lluis Colomo,Lluis Colomo,Antonio Martinez,Antonio Martinez,Giovanna Roncador,Giovanna Roncador,Emili Montserrat,Emili Montserrat,Elias Campo,Elias Campo,Alison H. Banham,Alison H. Banham +16 more
TL;DR: In conclusion, high Treg numbers predict improved survival of follicular lymphoma patients, while a marked reduction in Tregs is observed on transformation to DLBCL.
Journal ArticleDOI
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Sílvia Beà,Rafael Valdés-Mas,Alba Navarro,Itziar Salaverria,David Martín-García,Pedro Jares,Eva Giné,Magda Pinyol,Cristina Royo,Ferran Nadeu,Laura Conde,Manel Juan,Guillem Clot,Pedro Vizán,Luciano Di Croce,Diana A. Puente,Mónica López-Guerra,Alexandra Moros,Gaël Roué,Marta Aymerich,Neus Villamor,Lluis Colomo,Antonio Martinez,Alexandra Valera,José I. Martín-Subero,Virginia Amador,Luis Hernández,María Rozman,Anna Enjuanes,Pilar Forcada,Ana Muntañola,Elena Hartmann,María José Calasanz,Andreas Rosenwald,German Ott,Jesús M. Hernández-Rivas,Wolfram Klapper,Reiner Siebert,Adrian Wiestner,Wyndham H. Wilson,Dolors Colomer,Armando López-Guillermo,Carlos López-Otín,Xose S. Puente,Elias Campo +44 more
TL;DR: This study identifies molecular mechanisms contributing to MCL pathogenesis and offers potential targets for therapeutic intervention.
Journal ArticleDOI
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
Lluis Colomo,Armando López-Guillermo,Armando López-Guillermo,María Perales,María Perales,Susana Rives,Susana Rives,Antonio Martinez,Antonio Martinez,Francesc Bosch,Francesc Bosch,Dolors Colomer,Dolors Colomer,Brunangelo Falini,Brunangelo Falini,Emili Montserrat,Emili Montserrat,Elias Campo,Elias Campo +18 more
TL;DR: In conclusion, differentiation profile was associated with particular clinicopathological features but was not essential to predicting outcome in DLBCL patients.
Journal ArticleDOI
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
Lluis Colomo,Florence Loong,Susana Rives,Stefania Pittaluga,Antonio Fernández Martínez,Armando López-Guillermo,Jesus Ojanguren,Vicens Romagosa,Elaine S. Jaffe,Elias Campo +9 more
TL;DR: DLBCLs with plasmablastic differentiation are a heterogeneous group of neoplasms with different clinicopathological characteristics that may correspond to different entities.
Journal ArticleDOI
High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
Joaquim Carreras,Armando López-Guillermo,Giovanna Roncador,Neus Villamor,Lluis Colomo,Antonio Fernández Martínez,Rifat Hamoudi,William J. Howat,Emili Montserrat,Elias Campo +9 more
TL;DR: A high content of PD-1-positive cells predicted favorable outcome of follicular lymphoma patients, whereas a marked reduction is observed in transformation.